321 related articles for article (PubMed ID: 37082787)
1. Cutaneous infection caused by Purpureocillium lilacinum: Case reports and literature review of infections by Purpureocillium and Paecilomyces in Taiwan.
Lu KL; Wang YH; Ting SW; Sun PL
J Dermatol; 2023 Aug; 50(8):1088-1092. PubMed ID: 37082787
[TBL] [Abstract][Full Text] [Related]
2. Recurrent cutaneous hyalohyphomycosis secondary to Purpureocillium lilacinum in an immunocompetent individual.
McGeachie DL; Boyce AE; Miller RM
Australas J Dermatol; 2021 Aug; 62(3):e411-e413. PubMed ID: 34170516
[TBL] [Abstract][Full Text] [Related]
3. An unusual case of hyalohyphomycosis due to
Raghavan R; Chithra G; Fernandez S; Shamana Suryanarayana B; Singh R
Curr Med Mycol; 2018 Jun; 4(2):36-39. PubMed ID: 30324156
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous hyalohyphomycosis caused by Purpureocillium lilacinum in an immunocompetent patient: case report and review.
Saghrouni F; Saidi W; Ben Said Z; Gheith S; Ben Said M; Ranque S; Denguezli M
Med Mycol; 2013 Aug; 51(6):664-8. PubMed ID: 23330674
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus: report of three cases and review of the literature.
Hall VC; Goyal S; Davis MD; Walsh JS
Int J Dermatol; 2004 Sep; 43(9):648-53. PubMed ID: 15357743
[TBL] [Abstract][Full Text] [Related]
6. First reported case of subcutaneous hyalohyphomycosis caused by Paecilomyces variotii.
Vasudevan B; Hazra N; Verma R; Srinivas V; Vijendran P; Badad A
Int J Dermatol; 2013 Jun; 52(6):711-3. PubMed ID: 23679876
[TBL] [Abstract][Full Text] [Related]
7. Purpureocillium, a new genus for the medically important Paecilomyces lilacinus.
Luangsa-Ard J; Houbraken J; van Doorn T; Hong SB; Borman AM; Hywel-Jones NL; Samson RA
FEMS Microbiol Lett; 2011 Aug; 321(2):141-9. PubMed ID: 21631575
[TBL] [Abstract][Full Text] [Related]
8. Fatal hyalohyphomycosis with cutaneous involvement caused by Purpureocillium lilacinum in an immunocompromised patient with bullous pemphigoid.
Corbeddu M; Ferreli C; Cappai R; Ferraguti P; Atzori L; Pilloni L; Rongioletti F
Acta Biomed; 2021 Jul; 92(3):e2021139. PubMed ID: 34212928
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous Hyalohyphomycosis and Its Atypical Clinical Presentations in Immunosuppressed Patients.
Ferara N; Špoljar S; Lugović-Mihić L; Gverić Grginić A; Rezo Vranješ V; Bešlić I; Perović J; Regović Džombeta T
Life (Basel); 2024 Jan; 14(1):. PubMed ID: 38276283
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus in an immunocompetent host successfully treated with itraconazole: case report and review.
Gutiérrez-Rodero F; Moragón M; Ortiz de la Tabla V; Mayol MJ; Martín C
Eur J Clin Microbiol Infect Dis; 1999 Nov; 18(11):814-8. PubMed ID: 10614958
[TBL] [Abstract][Full Text] [Related]
11. Neglected and emerging fungal infections: review of hyalohyphomycosis by Paecilomyces lilacinus focusing in disease burden, in vitro antifungal susceptibility and management.
Antas PR; Brito MM; Peixoto É; Ponte CG; Borba CM
Microbes Infect; 2012 Jan; 14(1):1-8. PubMed ID: 21907304
[TBL] [Abstract][Full Text] [Related]
12. Invasive infections with Purpureocillium lilacinum: clinical characteristics and outcome of 101 cases from FungiScope® and the literature.
Sprute R; Salmanton-García J; Sal E; Malaj X; Ráčil Z; Ruiz de Alegría Puig C; Falces-Romero I; Barać A; Desoubeaux G; Kindo AJ; Morris AJ; Pelletier R; Steinmann J; Thompson GR; Cornely OA; Seidel D; Stemler J;
J Antimicrob Chemother; 2021 May; 76(6):1593-1603. PubMed ID: 33599275
[TBL] [Abstract][Full Text] [Related]
13. Topical voriconazole therapy of Purpureocillium lilacinum keratitis that occurred in disposable soft contact lens wearers.
Todokoro D; Yamada N; Fukuchi M; Kishi S
Int Ophthalmol; 2014 Oct; 34(5):1159-63. PubMed ID: 24974133
[TBL] [Abstract][Full Text] [Related]
14. Purpureocillium lilacinum tattoo-related skin infection in a kidney transplant recipient.
Trinh SA; Angarone MP
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28273390
[TBL] [Abstract][Full Text] [Related]
15. Species Identification and In Vitro Antifungal Susceptibility of
Monpierre L; Aït-Ammar N; Valsecchi I; Normand AC; Guitard J; Riat A; Huguenin A; Bonnal C; Sendid B; Hasseine L; Raberin H; Dehais M; Ranque S; Hennequin C; Piarroux R; Dannaoui E; Botterel F
J Fungi (Basel); 2022 Jun; 8(7):. PubMed ID: 35887446
[No Abstract] [Full Text] [Related]
16. A case of non-traumatic
Bennett HY; Shah SP
Am J Ophthalmol Case Rep; 2022 Jun; 26():101375. PubMed ID: 35243147
[TBL] [Abstract][Full Text] [Related]
17. Keratomycosis due to
Juyal D; Pal S; Sharma M; Negi V; Adekhandi S; Tyagi M
Indian J Pathol Microbiol; 2018; 61(4):607-609. PubMed ID: 30303164
[TBL] [Abstract][Full Text] [Related]
18. Successful Treatment of Paecilomyces lilacinus Onychomycosis with Efinaconazole and Tavaborole.
Evans JM; Wang AL; Elewski BE
Skin Appendage Disord; 2016 May; 1(4):169-71. PubMed ID: 27386459
[TBL] [Abstract][Full Text] [Related]
19. ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others.
Tortorano AM; Richardson M; Roilides E; van Diepeningen A; Caira M; Munoz P; Johnson E; Meletiadis J; Pana ZD; Lackner M; Verweij P; Freiberger T; Cornely OA; Arikan-Akdagli S; Dannaoui E; Groll AH; Lagrou K; Chakrabarti A; Lanternier F; Pagano L; Skiada A; Akova M; Arendrup MC; Boekhout T; Chowdhary A; Cuenca-Estrella M; Guinea J; Guarro J; de Hoog S; Hope W; Kathuria S; Lortholary O; Meis JF; Ullmann AJ; Petrikkos G; Lass-Flörl C; ;
Clin Microbiol Infect; 2014 Apr; 20 Suppl 3():27-46. PubMed ID: 24548001
[TBL] [Abstract][Full Text] [Related]
20. Treatment of resistant Paecilomyces lilacinus keratitis with topical voriconazole and oral itraconazole: a rare case report from Somalia.
Mohamed HM; Hassan IA; Yussuf AA; Nor YA; Ahmed AA; Roble AA
Ann Med Surg (Lond); 2024 Apr; 86(4):2172-2175. PubMed ID: 38576982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
